[go: up one dir, main page]

ES2166834T3 - Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus. - Google Patents

Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.

Info

Publication number
ES2166834T3
ES2166834T3 ES95941044T ES95941044T ES2166834T3 ES 2166834 T3 ES2166834 T3 ES 2166834T3 ES 95941044 T ES95941044 T ES 95941044T ES 95941044 T ES95941044 T ES 95941044T ES 2166834 T3 ES2166834 T3 ES 2166834T3
Authority
ES
Spain
Prior art keywords
treatment
herpesvirus
antivirical
profilaxis
aminopurin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95941044T
Other languages
English (en)
Inventor
Hugh John Field
Alana Maureen Thackray
Teresa Helen Bacon
David Sutton
Hodge Richard Anthony Vere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2166834(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of ES2166834T3 publication Critical patent/ES2166834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO PARA EL TRATAMIENTO DE INFECCIONES LATENTES DE HERPESVIRUS EN MAMIFEROS, INCLUIDOS HUMANOS, QUE INCLUYE LA ADMINISTRACION A LOS MAMIFEROS QUE NECESITAN DICHO TRATAMIENTO DE UNA CANTIDAD EFECTIVA DE UN COMPUESTO DE FORMULA (A) O UN BIOPRECURSOR, O UNA SAL FARMACEUTICAMENTE ACEPTABLE, UN ESTER FOSFATO Y/O UN DERIVADO ACILO DE ALGUNO DE LOS PRECEDENTES.
ES95941044T 1994-12-12 1995-11-23 Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus. Expired - Lifetime ES2166834T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses

Publications (1)

Publication Number Publication Date
ES2166834T3 true ES2166834T3 (es) 2002-05-01

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95941044T Expired - Lifetime ES2166834T3 (es) 1994-12-12 1995-11-23 Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.

Country Status (24)

Country Link
US (2) US5840763A (es)
EP (1) EP0799039B1 (es)
JP (1) JP2008088189A (es)
CN (1) CN1098687C (es)
AP (1) AP669A (es)
AT (1) ATE208198T1 (es)
AU (1) AU699627B2 (es)
BG (1) BG63815B1 (es)
BR (1) BR9509986A (es)
CA (1) CA2207503C (es)
CY (1) CY2339B1 (es)
CZ (1) CZ291545B6 (es)
DE (1) DE69523776T2 (es)
DK (1) DK0799039T3 (es)
ES (1) ES2166834T3 (es)
HK (1) HK1003259A1 (es)
HU (1) HU222835B1 (es)
NO (1) NO313862B1 (es)
NZ (1) NZ297424A (es)
PT (1) PT799039E (es)
RO (1) RO120042B1 (es)
SI (1) SI0799039T1 (es)
SK (1) SK282983B6 (es)
WO (1) WO1996018396A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CL2006000697A1 (es) * 2005-03-30 2008-05-09 Novartis Ag Uso de famciclovir para el tratamiento del herpes labial recurrente.
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
EP0799039B1 (en) 2001-11-07
AP669A (en) 1998-09-04
BR9509986A (pt) 1997-11-25
US5916893A (en) 1999-06-29
EP0799039A1 (en) 1997-10-08
NO972688D0 (no) 1997-06-11
CZ291545B6 (cs) 2003-04-16
AU4257896A (en) 1996-07-03
DE69523776T2 (de) 2002-08-01
CY2339B1 (en) 2004-02-06
SI0799039T1 (en) 2002-06-30
HUT77437A (hu) 1998-04-28
HK1003259A1 (en) 1998-10-23
SK282983B6 (sk) 2003-01-09
AP9701001A0 (en) 1997-07-31
PT799039E (pt) 2002-04-29
AU699627B2 (en) 1998-12-10
NO313862B1 (no) 2002-12-16
NZ297424A (en) 2000-07-28
JP2008088189A (ja) 2008-04-17
CA2207503A1 (en) 1996-06-20
SK75197A3 (en) 1997-11-05
ATE208198T1 (de) 2001-11-15
CN1175212A (zh) 1998-03-04
BG101608A (en) 1998-02-27
MX9704336A (es) 1997-09-30
WO1996018396A1 (en) 1996-06-20
BG63815B1 (bg) 2003-02-28
HU222835B1 (hu) 2003-11-28
CA2207503C (en) 2006-07-18
DE69523776D1 (de) 2001-12-13
DK0799039T3 (da) 2002-01-28
CZ179997A3 (en) 1997-09-17
NO972688L (no) 1997-08-07
RO120042B1 (ro) 2005-08-30
CN1098687C (zh) 2003-01-15
US5840763A (en) 1998-11-24

Similar Documents

Publication Publication Date Title
ES2113652T3 (es) Pamoato de risperidona.
CA2002859A1 (en) Method of treating epithelial disorders
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
DK0527787T3 (da) Fremgangsmåde til prædisponering af pattedyr for accelereret vævsheling
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
EA200100202A1 (ru) 4-карбоксиамино-2-замещенные-1,2,3,4-тетрагидрохинолины в качестве сетр-ингибиторов
EP0313305A3 (en) Photoprotection compositions comprising chelating agents
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
EA199800667A1 (ru) Новые фенантридины
ES2196054T3 (es) Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos.
EP0712389A4 (en) THERAPEUTIC COMPOUND FATTY ACID CONJUGATES
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
BR8801410A (pt) Composicao fotoendurecivel
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
ES8207156A1 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
FI832730A0 (fi) Trifenylimidazolyloxialkansyror och derivat daerav samt foerfaranden foer deras framstaellning
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
PT97680A (pt) Processo para preparacao de novos compostos sulfonilo e de composicoes farmaceuticas que os contem
PT92146A (pt) Processo para a preparacao do inibidor de glicosidade salbostatina e de composicoes farmaceuticas que a contem
CO5261493A1 (es) Procedimiento y compuestos para la inhibicion de la mrp1
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
NO970631L (no) Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider